Safety, Pharmacokinetics, and Plasmodium Falciparum Transmission-reducing Activity of Monoclonal Antibody TB31F in Mali
Clinical trial NCT06413108 · COMPLETED
Trial details
- NCT number
- NCT06413108
- Sponsor
- Radboud University Medical Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-12
- Primary completion
- 2026-01-16
- Enrollment
- 167
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.